Key Takeaways
- Staphyt and GenoScreen have signed a strategic collaboration agreement.
- The partnership integrates genomics, regulatory studies, and field trials into a single offering.
- The collaboration targets agro-industry and biosolutions companies developing microbial products.
- The joint approach supports product development from proof-of-concept to regulatory validation.
- Both organizations aim to address growing regulatory and scientific complexity in agriculture.
Staphyt and GenoScreen Establish Integrated Service Model for Agriculture
Staphyt, a contract research organization and regulatory affairs consultant specializing in agricultural experimentation and risk assessment, and GenoScreen, a provider of genomic and bioinformatics solutions, have announced a strategic collaboration agreement.
The partnership brings together GenoScreen’s genomic technologies with Staphyt’s expertise in regulatory studies and experimental trials. According to the companies, the objective is to provide agro-industry and biosolutions stakeholders with an integrated solution that supports the full product development lifecycle, from early scientific validation to regulatory field trials.
Addressing Regulatory and Scientific Demands in Biosolutions
The development of microbial products, including biostimulants and biocontrol solutions, increasingly depends on precise genomic characterization. These analyses are required to meet European regulatory standards related to identification, traceability, safety, and efficacy.
